You are invited to participate in a paid market research study about your personal experience with underactive bladder (UAB), which may also be known as impaired bladder emptying, hypotonic/flaccid bladder, detrusor underactivity/failure, voiding dysfunction, or chronic/acute urinary retention. The market research firm conducting the study would like to understand more about your personal journey and discuss potential new diagnostic and treatment options. In order to participate, you must have been diagnosed with UAB. The study consists of a 45-minute phone interview that will require internet access, and you will be compensated $100 for your time. If you are interested in participating, please click this link to see if you qualify: https://hub.m3globalresearch.com/page/r13650tdip.cfm This study is being managed by ZS, an Independent Research Firm, in compliance with marketing research standards. The study concludes on February 8, 2017.
Revolutionary Skin Protectant Finally Gives Nurses the Power to Stop, Reverse and Prevent Incontinence Associated Dermatitis
As our aging population grows, nurses are continuing to see more instances of tough-to-manage skin breakdown due to incontinence. Skin damage associated with urine and/or fecal exposure, otherwise known as incontinence associated dermatitis (IAD), is a resource-intensive condition that can be very painful for patients. To help combat this debilitating problem, 3M introduces its revolutionary 3M™ Cavilon™ Advanced Skin Protectant, a high endurance skin protectant designed to stop, reverse and prevent the damaging effects of moderate to severe IAD. The new skin protectant provides clinicians with an easier, more effective way to manage patients with IAD to help improve their quality of life and overall patient experience. Read more.
Source: Business Wire, February 1, 2017
AUA, Urology Care Foundation Applaud Introduction Of Resolution Supporting November As “National Bladder Health Month”
The American Urological Association (AUA) and the Urology Care Foundation, together with the Bladder Health Alliance – a coalition of groups representing physicians, patients and veterans – applauded Congressman Eliot Engel (NY-16) for his introduction of House Resolution 67, a measure supporting the designation of November 2017 as “National Bladder Health Month.” Read more.
Source: PRNewswire, January 30, 2017
Drug May Be New Weapon Against a ‘Superbug’
A newly approved drug may help in the battle against Clostridium difficile — a potentially fatal “superbug” gut infection that has become a scourge in U.S. hospitals. In two clinical trials, researchers found that the drug, called bezlotoxumab (Zinplava), cut the risk of a recurrent C. difficile infection by almost 40 percent. That’s important, because the gut infection commonly comes back after treatment with antibiotics — around 20 percent of the time, according to the U.S. Centers for Disease Control and Prevention. Read more.
HealthDay News, January 25, 2017
Trulance Approved for Chronic Constipation
Trulance (plecanatide) has been approved by the U.S. Food and Drug Administration to treat persistent constipation of unknown (idiopathic) cause in adults. Some 42 million people in the United States are affected by constipation, according to the National Institutes of Health. Once-daily Trulance is designed to stimulate the upper gastrointestinal tract to secrete fluid and “support regular bowel function,” the FDA said in a news release. Read more.
Source: HealthDay News, January 20, 2017
Axonics Sacral Neuromodulation System Receives Marketing Approval
Axonics Modulation Technologies, Inc. announced today that it received a Homologation d’un instrument médical (medical device approval) for the first rechargeable Sacral Neuromodulation (r-SNM™) System® to treat Overactive Bladder (OAB), Fecal Incontinence and Urinary Retention. The Health Canada license confirms that the Axonics® product meets all of the Canadian Medical Devices Regulations, Section 36, for Active Implantable Medical Devices and enables Axonics to market its r-SNM System throughout Canada. Read more.
Source: Yahoo! Finance, January 5, 2017
Strong Muscles Tied to Lower Risk of Incontinence in Older Women
Women who have more lean muscle mass or better grip strength may be less likely to experience a common type of urinary incontinence, a study suggests. That’s because strong muscles may help counter what’s known as stress urinary incontinence, which happens when the pelvic floor muscles supporting the bladder are too weak to prevent urine leaks when people do things like cough, sneeze or exercise. Childbirth is a common reason for weak pelvic muscles, and obesity makes the problem worse. Read more.
Source: WHBL, December 15, 2016
StimGuard Enrolls First Patient in Office-Based Chronic Tibial Nerve OAB Incontinence Stimulation Study Utilizing the World’s Smallest Wireless System
StimGuard, a privately-held, pre-commercial stage medical device company, today announced the initiation and the first patient enrollment in a clinical trial of the world’s first miniature implantable device for the treatment of urgency urinary incontinence resulting from refractory overactive bladder (OAB) syndrome. The StimGuard device utilizes wireless technology and is placed through an introducer device the size of a needle at the tibial nerve to activate the afferent micturition (neural urinary) pathways. The clinical trial of this novel approach will launch this winter. Read more.
Source: Business Wire, December 15, 2016
Cytori Pivotal ADRESU Incontinence Trial Hits 50% Enrollment Milestone
Cytori Therapeutics, Inc. (CYTX) today announced that over half of 45 patients in the ADRESU trial in Japan have been enrolled and treated. ADRESU is a late phase, investigator-initiated Japanese clinical trial to study the efficacy and safety of Cytori Cell TherapyTM in men with stress urinary incontinence after prostatic intervention for prostate cancer or benign prostatic hypertrophy. Read more.
Source: Yahoo! Finance, December 14, 2016
When Bathroom Runs Rule the Day (and Night)
I have only one regret about not having been born a male, and it concerns plumbing, namely how easy it is for men to eliminate liquid waste, whether by avoiding long bathroom lines or being able to relieve themselves discreetly when no facility is available. My male envy grew after I contracted poison ivy on unmentionable parts when nature called during a hike in the woods. Urination has long been a vexing problem for women. Read more.
Source: New York Times, December 12, 2016